Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nicholas Livingston, Xenia Leviyah, Victoria Ameral, Elise Hocking & Christine Timko. (2022) Scoping review of intervention studies to improve opioid and alcohol use outcomes and links to care following inpatient detoxification. Addiction Research & Theory 30:2, pages 134-148.
Read now
Read now
Michael P. Bogenschutz, Snehal Bhatt, Juliane Bohan, Bellelizabeth Foster, Paul Romo, Claire E. Wilcox & J. Scott Tonigan. (2016) Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study. The American Journal of Drug and Alcohol Abuse 42:5, pages 490-499.
Read now
Read now
Articles from other publishers (18)
Ivica Mladenovic, Ivana Perunicic-Mladenovic & Ivan Dimitrijević. (2023) Clinical and Background Risk Factors Affecting Dropouts from Alcohol Use Disorder Treatment: a 25-Year Retrospective Study. International Journal of Mental Health and Addiction.
Crossref
Crossref
Kiran Punia, William Scott, Kriti Manuja, Monica Sabbineni, Kaitryn Campbell, Iris M. Balodis & James MacKillop. (2023)
Anti‐craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence for
SAEM GRACE
. Academic Emergency Medicine.
Crossref
Crossref
Anna Arakelyan, Jürgen Kempkensteffen & Uwe Verthein. (2021) Systematische Literaturübersicht der Wirksamkeit von
Acamprosat, Naltrexon, Disulfiram und Nalmefen zur Trinkmengenreduktion und
Aufrechterhaltung der Abstinenz bei Alkoholabhängigkeit. Suchttherapie 24:01, pages 36-48.
Crossref
Crossref
Waisley Yang, Rohit Singla, Oshin Maheshwari, Christine J. Fontaine & Joana Gil-Mohapel. (2022) Alcohol Use Disorder: Neurobiology and Therapeutics. Biomedicines 10:5, pages 1192.
Crossref
Crossref
Claire K. Morice, Luba Yammine, Jin Yoon, Scott D. Lane, Joy M. Schmitz, Thomas R. Kosten, Richard De La GarzaIIII & Christopher D. Verrico. (2022) Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents. Progress in Neuro-Psychopharmacology and Biological Psychiatry 115, pages 110506.
Crossref
Crossref
Nicholas Livingston, Victoria Ameral, Elise Hocking, Xenia Leviyah & Christine Timko. (2022) Interventions to Improve Post-Detoxification Treatment Engagement and Alcohol Recovery: Systematic Review of Intervention Types and Effectiveness. Alcohol and Alcoholism 57:1, pages 136-150.
Crossref
Crossref
Peter M. Meggyesy, Shashank Masaldan, Sharnel A. S. Clatworthy, Irene Volitakis, Daniel J. Eyckens, Kathryn Aston-Mourney & Michael A. Cater. (2020) Copper Ionophores as Novel Antiobesity Therapeutics. Molecules 25:21, pages 4957.
Crossref
Crossref
Melissa R. Schick, Nichea S. Spillane & Katherine L. Hostetler. (2020) A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 44:10, pages 1933-1951.
Crossref
Crossref
Julia Sinclair & Lesley Peters. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
454
494
.
Sarah Oh, Yeong Ju, San Lee & Eun-Cheol Park. (2019) Primary Reason for Drinking Among Current, Former, and Never Flushing College Students. International Journal of Environmental Research and Public Health 16:2, pages 211.
Crossref
Crossref
Avinash De SousaAvinash De Sousa. 2019. Disulfiram. Disulfiram
21
30
.
Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip & Magdalena Bujalska-Zadrozny. (2016) Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?. Neurotoxicity Research 30:4, pages 698-714.
Crossref
Crossref
Julia M. A. Sinclair, Sophia E. Chambers, Celia J. Shiles & David S. Baldwin. (2016) Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence. Drug Safety 39:7, pages 627-645.
Crossref
Crossref
Marilyn D. Skinner, Pierre Lahmek, Héloïse Pham & Henri-Jean Aubin. (2014) Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis. PLoS ONE 9:2, pages e87366.
Crossref
Crossref
Atsushi Yoshimura, Mitsuru Kimura, Hisakazu Nakayama, Toshifumi Matsui, Fukiko Okudaira, Shigeru Akazawa, Masao Ohkawara, Tetsuji Cho, Yoshihiro Kono, Koji Hashimoto, Masayuki Kumagai, Yukiko Sahashi, Sungwon Roh & Susumu Higuchi. (2014) Efficacy of Disulfiram for the Treatment of Alcohol Dependence Assessed with a Multicenter Randomized Controlled Trial. Alcoholism: Clinical and Experimental Research 38:2, pages 572-578.
Crossref
Crossref
Fares Alharbi & Nady el-Guebaly. (2012) Disulfiram. Addictive Disorders & Their Treatment 11:4, pages 212-223.
Crossref
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Crossref
Charlotte H. Jørgensen, Bolette Pedersen & Hanne Tønnesen. (2011) The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 35:10, pages 1749-1758.
Crossref
Crossref